Latest News

Reolink Introduces the Solar Floodlight Cam During Its Annual Spring Event, Offering Smart AI-Powered, Wire-free Outdoor Security at a Special Price

LOS ANGELES, March 25, 2026 /PRNewswire/ -- Reolink, an innovative leader in intelligent visual technology for homes and businesses, introduces its Solar Floodlight Cam during its Annual Spring Sale, offering its newest camera design at a special price in addition to amazing deals on some of Reol...

2026-03-25 21:08 5148

Next-Gen K-Beauty Brand Dr.BRID C Unveils "40,000ft Barrier Collection" with Up to 40% Off Spring Promotion

Featuring its signature cream proven to endure the Sahara-like dryness of airplane cabins, the brand is offering up to 40% off its entire barrier-care lineup for the US spring shopping season. NEW YORK and SEOUL, South Korea, March 25, 2026 /PRNewswire/ -- Dr.BRID C, a next-generation K-beauty s...

2026-03-25 21:08 4416

Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics

SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a lar...

2026-03-25 21:01 4759

From seeing to clarity: 3 must-buy 70mai Dash Cams this Spring Sale

SHANGHAI, March 25, 2026 /PRNewswire/ -- 70mai, a global smart car electronics company with a specialization in dashboard cameras, today announced the launch of its Spring Sale to help millions of road-trippers stay protected.With discounts of up to 44%, advanced dash cam technology is now availa...

2026-03-25 21:00 3018

GIBO Expands GIBO Watch with "Digital Canvas" -- A Next-Generation Generative Pipeline for Short Film Creation

KUALA LUMPUR, Malaysia, March 25, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), a global technology company focused on AI-driven content infrastructure, today announced the launch of the"Digital Canvas" within its GIBO Watch framework—a next-generation generative pipeline designed to em...

2026-03-25 21:00 5514

K-Beauty Manufacturer KM Pharmaceutical (KOSDAQ: 225430) Expands Global Skincare and Oral Care OEM/ODM Platform with Advanced Functional Product Portfolio

SEOUL, South Korea, March 25, 2026 /PRNewswire/ -- KM Pharmaceutical Co., Ltd. (KOSDAQ: 225430), a leading K-beauty manufacturer specializing in skincare, oral care, and private label OEM/ODM production, is strengthening its global position by expanding into high-value functional product categori...

2026-03-25 21:00 3630

TOYO Co., Ltd Schedules Second Half and Fiscal Year 2025 Earnings Release and Conference Call Date

TOKYO, March 25, 2026 /PRNewswire/ -- TOYO Co., Ltd (NASDAQ: TOYO) (OTC: TOYWF), a solar solutions company, today announced that it will host a conference call to discuss its second half and fiscal year 2025 results on Tuesday, March 31, 2026. Conference Call Detail...

2026-03-25 20:30 4815

Erayak Strategic Roadmap: Providing a High-Precision Energy Defense Against Global Oil and Grid Volatility

Optimizing Tri-Fuel "Infinite Runtime" and Utility-Grade Power Quality to Shield Modern Households from Energy Crises WENZHOU, China, March 25, 2026 /PRNewswire/ -- Erayak Power Solution Group Inc. (Nasdaq: RAYA) ("Erayak" or the "Company"), a leading developer of ...

2026-03-25 20:05 4361

Cheche Group Schedules Second Half and FY 2025 Earnings Release and Conference Call Date

BEIJING, March 25, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced it will host a conference call to discuss results for the Second Half and Full Year 2025 on T...

2026-03-25 20:00 4351

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics ...

2026-03-25 20:00 4645

Nota AI and SiMa.ai Sign Strategic Partnership for Physical AI Technology Collaboration

"Combining AI Optimization with High Performance and Efficiency MLSoCs to Lead the Physical AI Market" * Nota AI's AI Optimization Technology Meets SiMa.ai's MLSoC™ Product Family, Maximizing On-Device AI Performance for Physical AI * Joint Development and Commercialization of AI Solutions fo...

2026-03-25 20:00 4637

AOTOS Launches the World's First Wheelie-Capable E-Moto: The Flux X26 on Kickstarter

NEW YORK, March 25, 2026 /PRNewswire/ -- AOTOS, a global pioneer in Human Mobility Robotics, has officially launched its flagship product on Kickstarter, the Flux X26 and X26 Pro. Representing the first physical manifestation of the company's vision, the Flux X26 is designed to bridge the gap bet...

2026-03-25 20:00 3470

Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics

- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an exclusive license agreement with Biogen Inc. for the...

2026-03-25 20:00 4061

Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

BEIJING, March 25, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited ("Kingsoft Cloud" or the "Company") (NASDAQ: KC and HKEX: 3896), a leading cloud service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Mr. ...

2026-03-25 19:57 4238

51Talk Online Education Group to Report Fourth Quarter and Full Year 2025 Financial Results on Friday, March 27, 2026

Earnings Call Scheduled for 8:00 a.m. ET on March 27, 2026 SINGAPORE, March 25, 2026 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, today announced that it will report i...

2026-03-25 19:20 5835

Tantech Holdings Ltd Announces Notice of Allowance from U.S. Patent and Trademark Office for Hanging Cabinet Design Patent

LISHUI, China, March 25, 2026 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) (the "Company" or "Tantech"), today announced that its U.S. subsidiary, Tanhome Group Inc., has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO) for a Hanging Cabinet d...

2026-03-25 18:30 4921

WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture

SHANGHAI, March 25, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has released its annual results for 2025, demonstrating record growth and a transformative leap in operational sophistication. Th...

2026-03-25 18:22 4996

Segway Powersports Debuts Super Villain at The Mint 400 with P3 Podium Finish

MCKINNEY, Texas, March 25, 2026 /PRNewswire/ -- Segway Powersports, a global innovator in intelligent off-road vehicles and connected riding systems, celebrated a triumphant debut at the legendary Mint 400, the iconic Las Vegas desert race and a key event in the American Off-Road Racing Champions...

2026-03-25 18:13 3768

HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering

Listing milestone positions HanchorBio to strengthen institutional visibility, advance itsFBDB™ platform, and expand a growing pipeline spanning oncology and broader immune-mediated diseases TAIPEI, SHANGHAI and SAN FRANCISCO, March 25, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a globa...

2026-03-25 18:00 3833

VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial

* Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 * A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatment * Fully biological transplant eliminates need for immunosuppres...

2026-03-25 17:11 3497
1 ... 35363738394041 ... 1693